Ora Pharm Limited 

  Early Stage Capital  

  

  Ora Pharm ltd  

WARNING

The law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors make an informed decision.

If you are an accredited investor under the definition of that term in Rule 501(a) of Regulation D of the US Securities Act of 1933, the usual rules do not apply to offers of financial products made to you. As a result, you may not receive a complete and balanced set of information.

You will also have fewer other legal protections for these investments. Ask questions, read all documents carefully, and seek independent financial advice before committing yourself.

Overview

The opportunity exists for Wholesale Investors to express interest in Ora Pharm Limited (Ora Pharm)


The Company


Ora Pharm is ideally positioned to become the leading New Zealand supplier of high value, pharmaceutical grade medicinal cannabis products to meet rapidly growing international and domestic demand. Ora Pharm is secured a location in North Waikato that is ideally suited to growing cannabis, both indoors (year-round) and outdoors (seasonally). Using specialized greenhouses developed in the US but little-known in the Southern Hemisphere, Ora Pharm is preparing to own the most efficient and productive growing facilities for cannabis in New Zealand.


In a market with very high regulatory barriers to entry and competitors beginning to operate, Ora Pharm stands out as the only company with significant market experience and a strong US market platform to drive growth. Zoe Reece (CEO and Founder) and Stuart Wilcox (Executive Chairman and Head of International Business Development) bring a wealth of experience having previously held senior executive positions at Curaleaf, one of the largest and most respected cannabis corporation in North America with a market capitalisation of over US$11.5 billion.


The Offer

Ora Pharm is seeking to raise up to NZ$11.5 million in equity capital through a Series A Funding Round from wholesale and institutional investors. The capital raised will support the expansion of cultivation capacity, develop processing and manufacturing capability and the freehold purchase of land.



For more information please refer to the Information Memorandum in the documents section.

To access further information and be put in contact with the arranger, Register Interest.



Issue Type:
Early Stage Capital
Sector:
Health Care
isEOI: true

Investment Details

Investment Type: Wholesale

Wholesale Investment Type: NZ Wholesale Equities

Transaction Size:NZD 11,500,000.00

Committed Capital: 

Pre-money valuation:NZD 22,500,000.00

Minimum Capital Raise:NZD 3,000,000.00

Share Price:NZD 0.00

Unit Price:NZD 3.55

Minimum Investment Size:NZD 50,000.00

Advisor

Bancorp Merchant Bankers

Website:

Email: [email protected]

Phone:+64 27 555 3520

Document Name Description Date Uploaded
Ora Pharm Information Memorandum Series A Funding Round - August 2021 Ora Pharm Information Memorandum Series A Funding Round - August 2021 23 September 2021 Preview/Download
Zoom: 0

You do not have any investments to report on.

No trade history available for this issue.

Secondary Market - Ora Pharm Limited Wholesale

No secondary market listings for this issue availble at this time. Check the Exchange for more listings.